Holen Sie sich die Stockscreener-App
17.96
1.10%
-0.20
Vorhandelsmarkt:
17.92
-0.04
-0.22%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt KVUE?
Forum
Prognose
Dividendenhistorie
Kenvue Inc Aktie (KVUE) Neueste Nachrichten
How Is Kenvue’s Stock Performance Compared to Other Consumer Staple Stocks? - Barchart.com
UBS Raises Kenvue Inc. (KVUE) Price Target to $19 After Strong Q4 Results - Finviz
My Top 3 Dividend Kings to Buy for March 2026 - The Motley Fool
Van ECK Associates Corp Buys 9,240,434 Shares of Kenvue Inc. $KVUE - MarketBeat
Richard Bernstein Advisors LLC Lowers Stock Position in Kenvue Inc. $KVUE - MarketBeat
Aveeno® announces research collaboration to advance skin health science and educationA new view of care - Kenvue
WINTON GROUP Ltd Takes Position in Kenvue Inc. $KVUE - MarketBeat
Korea Investment CORP Acquires 1,470,295 Shares of Kenvue Inc. $KVUE - MarketBeat
CI Investments Inc. Sells 519,412 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. $KVUE Position Reduced by Victory Capital Management Inc. - MarketBeat
Neuberger Berman Group LLC Grows Stake in Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark Kenvue Deal And New Tech Leader Reshape Growth Story - Yahoo Finance
Athos Capital Ltd Purchases Shares of 2,500,000 Kenvue Inc. $KVUE - MarketBeat
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: Kenvue, Inc. (KVUE) and Sysco (SYY) - The Globe and Mail
Is Kenvue (KVUE) Pricing Reflect Its Post Johnson & Johnson Spin Off Prospects - Yahoo Finance
Kenvue (KVUE): Barclays Adjusts Price Target to USD 19.00 | KVUE Stock News - GuruFocus
Tylenol use in pregnancy fell after Trump’s autism warning: study - Seeking Alpha
Tylenol use among women dropped after Trump tied it to autism, Lancet analysis shows - marketscreener.com
Kenvue (NYSE:KVUE) Given New $19.00 Price Target at Barclays - MarketBeat
Kenvue price target raised to $19 from $18 at Barclays - TipRanks
Kenvue Inc. $KVUE Stock Position Increased by Dimensional Fund Advisors LP - MarketBeat
Kenvue: Out Of Favor Then, Under Pressure Now (KVUE) - Seeking Alpha
Barclays raises Kenvue stock price target on category growth - Investing.com
Barclays raises Kenvue stock price target on category growth By Investing.com - Investing.com Nigeria
Burgundy Asset Management Ltd. Trims Holdings in Kenvue Inc. $KVUE - MarketBeat
Kenvue (NYSE: KVUE) grants CTO 79,407 RSUs vesting 2027-2029 - Stock Titan
Kenvue (NYSE: KVUE) grants 63,525 RSUs to Chief Scientific Officer - Stock Titan
Kenvue (KVUE) Valuation Revisited After Schafer Cullen Exit And Ongoing Consumer Headwinds - simplywall.st
US Bancorp DE Has $2.41 Million Stock Position in Kenvue Inc. $KVUE - MarketBeat
Skba Capital Management LLC Has $13.73 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
Elo Mutual Pension Insurance Co Has $4.44 Million Position in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. stock falls Tuesday, underperforms market - MarketWatch
Kenvue Inc (KVUE) Trading Down 3.2% on Mar 3 - GuruFocus
Zyrtec® joins PGA TOUR as the first official allergy relief sponsor - Kenvue
Kenvue Inc. $KVUE Shares Sold by Bahl & Gaynor Inc. - MarketBeat
APG Asset Management N.V. Has $18.23 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
Kenvue Shares Tumble 27.9% Below 52-Week High as Earnings Misses and Strategic Uncertainty Send Stock to 229th in Daily Trading Activity - Bitget
Will Strong Q4 Results and Schafer Cullen’s Exit Change Kenvue’s (KVUE) Investment Narrative? - simplywall.st
Kimberly-Clark Seeks Clearance To Acquire Kenvue - supermarketnews.co.nz
Kimberly-Clark seeks New Zealand clearance for Kenvue acquisition - MLex
Kenvue Inc. stock falls Monday, underperforms market - MarketWatch
Neutrogena agrees to $4.7M class action settlement over Skin360 biometric data - Class Action Lawsuits
Here’s Why SCCM Enhanced Equity Portfolio Exited Its Position in Kenvue (KVUE) - Insider Monkey
TD Asset Management Inc Sells 1,931,369 Shares of Kenvue Inc. $KVUE - MarketBeat
KVUE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Discipline and Rules-Based Execution in KVUE Response - Stock Traders Daily
Kenvue Inc. (KVUE): A Bull Case Theory - Finviz
Mitsubishi UFJ Asset Management Co. Ltd. Has $71.93 Million Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
American Century Companies Inc. Raises Stock Position in Kenvue Inc. $KVUE - MarketBeat
Westpac Banking Corp Sells 192,981 Shares of Kenvue Inc. $KVUE - MarketBeat
Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol safety - WHTC
Kenvue Inc. stock rises Thursday, outperforms market - MarketWatch
Tylenol maker announces layoffs ahead of Kimberly-Clark buyout - The Business Journals
Kenvue Bid to Dismiss Texas AG Lawsuit Rejected by Judge - marketscreener.com
Kenvue Bid to Dismiss Texas AG Lawsuit Rejected by Judge, Reuters Reports - marketscreener.com
Kenvue effort to dismiss Tylenol case rejected by Texas judge (KVUE:NYSE) - Seeking Alpha
Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol's safety - Yahoo
Judge rejects Kenvue bid to dismiss Texas Attorney General's lawsuit over marketing of Tylenol, court order shows - marketscreener.com
U.S. District Court for the District of New Jersey Judge Trims Benzene Class Claims Against Johnson & Johnson Consumer Inc. and Kenvue Inc. - USA Herald
NJ Judge Trims J&J and Neutrogena Benzene Suit - Law360
Kenvue Inc. stock falls Wednesday, underperforms market - MarketWatch
Kimberly-Clark Kenvue Deal Reshapes Growth Story And Investor Trade Offs - Yahoo Finance
Kenvue Agrees To $4.7 Million Skin360 Settlement - Happi | Household And Personal Products Industry
Assessing Kenvue (KVUE) Valuation As Recent Share Price Momentum Meets Mixed Longer Term Returns - simplywall.st
RBC Capital Reaffirms Their Hold Rating on Kenvue, Inc. (KVUE) - The Globe and Mail
Kenvue, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Metrics - Markets Mojo
1.77%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):